Artwork

Content provided by Sam Tarantino. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sam Tarantino or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

COVID19 Vaccine Distribution in Canada-- Industry Perspective

21:17
 
Share
 

Manage episode 337505498 series 3381582
Content provided by Sam Tarantino. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sam Tarantino or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Several COVID19 vaccine candidates are in development and launch plans are being drafted.

Progress is unfolding at an unprecedented pace. More than 200 potential vaccines are in development and more than 40 have entered human trials. Applications for approval have already been submitted to Health Canada under the Interim Order.

Canada, currently, has access to a guaranteed 174 million doses of potential COVID19 vaccines. This represents over $1 billion in advance purchase agreements

Canada has also pledged to the World Health Organisation's Advanced Market Commitment (AMC) $220 million to purchase 15 million vaccine doses from the COVAX facility plus $220 million to purchase doses for low- and middle-income countries.

Securing regulatory approval and supply agreements is a great first step, but how will the vaccine be rolled out safely and equitable as possible?

To help us understand how industry in Canada is preparing for the roll out, I’ve invited Daniel Chiasson, President and CEO, of the Canadian Association for Pharmacy Distribution Management (CAPDM).

  continue reading

26 episodes

Artwork
iconShare
 
Manage episode 337505498 series 3381582
Content provided by Sam Tarantino. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sam Tarantino or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Several COVID19 vaccine candidates are in development and launch plans are being drafted.

Progress is unfolding at an unprecedented pace. More than 200 potential vaccines are in development and more than 40 have entered human trials. Applications for approval have already been submitted to Health Canada under the Interim Order.

Canada, currently, has access to a guaranteed 174 million doses of potential COVID19 vaccines. This represents over $1 billion in advance purchase agreements

Canada has also pledged to the World Health Organisation's Advanced Market Commitment (AMC) $220 million to purchase 15 million vaccine doses from the COVAX facility plus $220 million to purchase doses for low- and middle-income countries.

Securing regulatory approval and supply agreements is a great first step, but how will the vaccine be rolled out safely and equitable as possible?

To help us understand how industry in Canada is preparing for the roll out, I’ve invited Daniel Chiasson, President and CEO, of the Canadian Association for Pharmacy Distribution Management (CAPDM).

  continue reading

26 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide